As was announced in early October, Sopahrama subscribed 108,500 shares from the capital of Latvian Olinepharma in the company's IPO.
And at the end of September Sopharma signed a contract with Polish Natur Product Zdrovit for the setting up of a joint company.
It became clear last month that Sopharma has made its first product registration on the Turkish market.
Metilprednizolon is an anti-inflammatory and anti-allergic medication that is widely used in urgent care and in cases of serious shocks or in chronic conditions, which are not affected by standard medications.
The stock dropped 1.8% to an average of 8.72 leva at a turnover f 15,744 shares.